EvenUp Review

This isn't a horizontal legal AI tool. It's a vertical play on personal injury demands, and the line-level citation verification plus the settlement/verdict database are real moats against Filevine or CASEpeer, which are case management first, not valuation-driven.

Contact-based pricing with no free trial means procurement friction up front. That's fine for a $2M+ revenue firm, less fine if you're testing appetite for AI in legal ops broadly.

SOC2 and HIPAA attestation matter here since medical records are core to the product, not an afterthought. The tradeoff: you're betting on a single-category vendor in a legal AI market that's still consolidating. If PI law isn't your firm's bread and butter, skip it entirely.

As GC-adjacent counsel for a PI practice, my first question is always attribution: who's liable when an AI-drafted demand misstates an injury or damages figure. EvenUp's line-level citation feature — checking every AI statement against source records — is the right architecture for that risk, not a nice-to-have. SOC2 audit and HIPAA attestation are table stakes given the volume of medical records flowing through, but at least they're stated plainly rather than buried.

The PLAAS model (Pre-Litigation-as-a-Service) bundles software with U.S.-based staff, which changes the vendor relationship from tool to quasi-outsourced function. That's a bigger commitment than deploying Filevine or CASEpeer as case management, and it's worth board-level scrutiny before signing.

Integration with SmartAdvocate, Litify, and CASEpeer means it layers onto existing CMS rather than replacing it — good for switching cost, but it means your firm's data now lives partly in EvenUp's proprietary settlement database, a lock-in vector no pricing page discloses.

No pricing page. No published tier. Just "contact sales." That's the whole model here — compare to Filevine or Litify, both also sales-led in this category, so EvenUp isn't unusual, just opaque.

TCO math is a black box without a quote. Firm size and case volume drive cost, per their own site. PLAAS bundles software with U.S.-based staffing — that's not a per-seat SaaS fee, that's a services contract. Year 3 cost depends entirely on case volume growth, and nothing here lets you model that in advance.

SOC2 and HIPAA attestation reduce one risk category: security review friction. But contract terms — auto-renewal window, termination clause, exhibit/data export format on offboarding — aren't disclosed anywhere in the evidence. For a platform holding medical records and case financials, that's the number procurement will actually ask for first.

Demand drafting is where paralegals live, and EvenUp's pitch — pull from the CMS, draft in the firm's tone, cite every line back to source records — hits the actual pain point. Not 'AI writes your letters,' but 'AI writes a first draft you can verify fast,' which is the difference between adoption and shelf-ware. Line-Level Citations matters more than the flashy trial-chronology stuff, because that's what keeps an attorney from having to redo my work.

Integration with SmartAdvocate, Litify, and CASEpeer means it sits on top of the CMS rather than replacing it, which is the right call — nobody's migrating case data twice.

Day-3 concern: Communication Agents making calls to insurance carriers and clients on my case files means I'm now reviewing AI conversation logs, not eliminating a task. And with no published pricing, no free trial, and a sales-call gate, I can't tell if this fits a five-attorney PI shop or only firms running Litify-scale volume.

No pricing page, no free trial, no docs. Everything routes through 'schedule a demo,' which tells me this is built for firm partners signing contracts, not the paralegal who'll live in it every day. That's fine for legal software, it's just the norm, but it means I can't tell you what day three feels like. Nobody outside a sales call has.

What's genuinely good on paper: line-level citations checking every AI statement against source records is the kind of feature that matters at 4pm when you're double-checking a demand letter before it goes out. The settlement/verdict database for valuation and CMS integrations with SmartAdvocate, Litify, and CASEpeer show they built for firms' actual workflows instead of asking firms to change.

But PLAAS bundles software with actual staffing, which blurs whether you're buying a tool or outsourcing casework. That's a bigger decision than most SaaS purchases, and the site gives you zero signal on cost or onboarding time to help you make it.

Three tells before the docs. One: 'leading' and 'proactive' in the H1 — the kind of superlative every legal AI vendor uses right now. Two: no pricing page, contact-sales only, category norm for this segment but still a friction point. Three: trademark symbols on nearly every feature name — Demands™, Piai™, Playbooks™ — which reads more like brand defense than product maturity.

What's actually solid: line-level citations against source records, CMS integrations with SmartAdvocate, Litify, and CASEpeer named explicitly, and a settlement/verdict dataset for valuation. That's a real wedge against Filevine and Litify, who are case management first, not AI-drafting first. EvenUp isn't replacing your CMS — it's sitting on top, which helps exit portability if this doesn't work out.

SOC2 and HIPAA-attested is table stakes for medical record handling, not a differentiator. PLAAS bundling software with staffing is the interesting bet — also the part that's hardest to unwind in 18 months if you've built workflow around their people.